Anna King appointed to UK Research and Innovation Board

29 October 2026
The Health Innovation Network (HIN) South London’s Commercial Director, Anna King, has been appointed as a non-executive member of the Board for UK Research and Innovation (UKRI), the national body responsible for investment in science, research and business innovation.

Her appointment comes at a pivotal moment for UK innovation, with UKRI’s new strategy 2026-31 setting out ambitious plans to use record-breaking levels of government funding to deliver against the biggest priorities for society and demonstrate even more positive outcomes from innovation.

Anna’s UKRI Board membership began in September 2026. Anna will combine her UKRI responsibilities with her continued leadership of commercial and innovator support functions at the HIN (including our multi award-winning DigitalHealth.London programmes) and as a Non-Executive Director at Lewisham and Greenwich NHS Trust.

UKRI’s mission is to advance knowledge, improve lives and drive growth, with access to investment as a key priority. Through initiatives such as Innovate UK’s Investor Partnerships programme, public grant funding is increasingly being combined with aligned equity investment from the private sector to help promising companies accelerate their growth while remaining rooted in the UK innovation ecosystem.

Commenting on her appointment, Anna said:

“I am delighted to have joined the UKRI Board, and I am looking forward to helping to shape an ecosystem where innovators and investors can work even more closely together to achieve real impact for society and UK PLC.

At the HIN, we support hundreds of the most promising health tech companies each year through DigitalHealth.London, Mindset-XR and a range of other programmes, and over the past few years we have strengthened our connections to funders and the world of finance through our Investor Panel.

It is clear from both sides of the table the enthusiasm that exists for achieving sustainable growth more quickly through innovative approaches to funding, and I see significant potential for using the insights we have gleaned through our regional and national programmes to achieve that goal.”

News

Latest

Applications open for the London Cardiovascular Renal Metabolic Fellowship 2026-27

Involvement opportunity: resident panel members to inform the development of community-based weight management services

National funding extension supports hundreds more Merton residents with respiratory conditions